Microbot Medical Inc. (FRA:CY9D)

Market Cap	117.43M +113.9%
Revenue (ttm)	n/a
Net Income	-11.14M
EPS	-0.33
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	308
Open	1.802
Previous Close	1.800
Day's Range	1.802 - 1.802
52-Week Range	1.214 - 4.268
Beta	n/a
RSI	56.33
Earnings Date	Mar 25, 2026

About Microbot Medical

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology i...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2010
• Employees: 20
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CY9D

Financial Performance

Financial numbers in USD